Pacific Biosciences of California, Inc. is a pharmaceutical company based in the United States that specializes in creating innovative sequencing solutions for scientists and researchers. With a low ESG risk rating score of 18.5, the company is focused on improving genetic understanding and solving complex genetic issues. Pacific Biosciences operates in the development, manufacturing, and marketing of a genetic analysis platform. The company generates most of its revenue from the Americas, with additional income from Asia-Pacific and Europe Middle East, and Africa.